Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant

Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these c...

Full description

Saved in:
Bibliographic Details
Published inEuropace (London, England) Vol. 17; no. 12; pp. 1823 - 1833
Main Authors Sohaib, S.M. Afzal, Kyriacou, Andreas, Jones, Siana, Manisty, Charlotte H., Mayet, Jamil, Kanagaratnam, Prapa, Peters, Nicholas S., Hughes, Alun D., Whinnett, Zachary I., Francis, Darrel P.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.12.2015
Subjects
Online AccessGet full text
ISSN1099-5129
1532-2092
1532-2092
DOI10.1093/europace/euu374

Cover

Abstract Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these conflicts. Twenty-two patients in sinus rhythm with existing CRT underwent VV optimization using non-invasive systolic blood pressure. Interventricular optimization was performed with four methods for keeping the AV delay constant: (i) atrium and left ventricle delay kept constant, (ii) atrium and right ventricle delay kept constant, (iii) time to the first-activated ventricle kept constant, and (iv) time to the second-activated ventricle kept constant. In 11 patients this was performed with AV delay of 120 ms, and in 11 at AV optimum. At AV 120 ms, time to the first ventricular lead (left or right) was the overwhelming determinant of haemodynamics (13.75 mmHg at ±80 ms, P < 0.001) with no significant effect of time to second lead (0.47 mmHg, P = 0.50), P < 0.001 for difference. At AV optimum, time to first ventricular lead again had a larger effect (5.03 mmHg, P < 0.001) than time to second (2.92 mmHg, P = 0.001), P = 0.02 for difference. Time to first ventricular activation is the overwhelming determinant of circulatory function, regardless of whether this is the left or right ventricular lead. If this is kept constant, the effect of changing time to the second ventricle is small or nil, and is not beneficial. In practice, it may be advisable to leave VV delay at zero. Specifying how AV delay is kept fixed might make future VV delay research more enlightening.
AbstractList Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these conflicts.AIMSWhether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these conflicts.Twenty-two patients in sinus rhythm with existing CRT underwent VV optimization using non-invasive systolic blood pressure. Interventricular optimization was performed with four methods for keeping the AV delay constant: (i) atrium and left ventricle delay kept constant, (ii) atrium and right ventricle delay kept constant, (iii) time to the first-activated ventricle kept constant, and (iv) time to the second-activated ventricle kept constant. In 11 patients this was performed with AV delay of 120 ms, and in 11 at AV optimum. At AV 120 ms, time to the first ventricular lead (left or right) was the overwhelming determinant of haemodynamics (13.75 mmHg at ±80 ms, P < 0.001) with no significant effect of time to second lead (0.47 mmHg, P = 0.50), P < 0.001 for difference. At AV optimum, time to first ventricular lead again had a larger effect (5.03 mmHg, P < 0.001) than time to second (2.92 mmHg, P = 0.001), P = 0.02 for difference.METHOD AND RESULTSTwenty-two patients in sinus rhythm with existing CRT underwent VV optimization using non-invasive systolic blood pressure. Interventricular optimization was performed with four methods for keeping the AV delay constant: (i) atrium and left ventricle delay kept constant, (ii) atrium and right ventricle delay kept constant, (iii) time to the first-activated ventricle kept constant, and (iv) time to the second-activated ventricle kept constant. In 11 patients this was performed with AV delay of 120 ms, and in 11 at AV optimum. At AV 120 ms, time to the first ventricular lead (left or right) was the overwhelming determinant of haemodynamics (13.75 mmHg at ±80 ms, P < 0.001) with no significant effect of time to second lead (0.47 mmHg, P = 0.50), P < 0.001 for difference. At AV optimum, time to first ventricular lead again had a larger effect (5.03 mmHg, P < 0.001) than time to second (2.92 mmHg, P = 0.001), P = 0.02 for difference.Time to first ventricular activation is the overwhelming determinant of circulatory function, regardless of whether this is the left or right ventricular lead. If this is kept constant, the effect of changing time to the second ventricle is small or nil, and is not beneficial. In practice, it may be advisable to leave VV delay at zero. Specifying how AV delay is kept fixed might make future VV delay research more enlightening.CONCLUSIONTime to first ventricular activation is the overwhelming determinant of circulatory function, regardless of whether this is the left or right ventricular lead. If this is kept constant, the effect of changing time to the second ventricle is small or nil, and is not beneficial. In practice, it may be advisable to leave VV delay at zero. Specifying how AV delay is kept fixed might make future VV delay research more enlightening.
Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these conflicts. Twenty-two patients in sinus rhythm with existing CRT underwent VV optimization using non-invasive systolic blood pressure. Interventricular optimization was performed with four methods for keeping the AV delay constant: (i) atrium and left ventricle delay kept constant, (ii) atrium and right ventricle delay kept constant, (iii) time to the first-activated ventricle kept constant, and (iv) time to the second-activated ventricle kept constant. In 11 patients this was performed with AV delay of 120 ms, and in 11 at AV optimum. At AV 120 ms, time to the first ventricular lead (left or right) was the overwhelming determinant of haemodynamics (13.75 mmHg at ±80 ms, P < 0.001) with no significant effect of time to second lead (0.47 mmHg, P = 0.50), P < 0.001 for difference. At AV optimum, time to first ventricular lead again had a larger effect (5.03 mmHg, P < 0.001) than time to second (2.92 mmHg, P = 0.001), P = 0.02 for difference. Time to first ventricular activation is the overwhelming determinant of circulatory function, regardless of whether this is the left or right ventricular lead. If this is kept constant, the effect of changing time to the second ventricle is small or nil, and is not beneficial. In practice, it may be advisable to leave VV delay at zero. Specifying how AV delay is kept fixed might make future VV delay research more enlightening.
Author Kanagaratnam, Prapa
Manisty, Charlotte H.
Mayet, Jamil
Francis, Darrel P.
Sohaib, S.M. Afzal
Kyriacou, Andreas
Jones, Siana
Hughes, Alun D.
Whinnett, Zachary I.
Peters, Nicholas S.
Author_xml – sequence: 1
  givenname: S.M. Afzal
  surname: Sohaib
  fullname: Sohaib, S.M. Afzal
– sequence: 2
  givenname: Andreas
  surname: Kyriacou
  fullname: Kyriacou, Andreas
– sequence: 3
  givenname: Siana
  surname: Jones
  fullname: Jones, Siana
– sequence: 4
  givenname: Charlotte H.
  surname: Manisty
  fullname: Manisty, Charlotte H.
– sequence: 5
  givenname: Jamil
  surname: Mayet
  fullname: Mayet, Jamil
– sequence: 6
  givenname: Prapa
  surname: Kanagaratnam
  fullname: Kanagaratnam, Prapa
– sequence: 7
  givenname: Nicholas S.
  surname: Peters
  fullname: Peters, Nicholas S.
– sequence: 8
  givenname: Alun D.
  surname: Hughes
  fullname: Hughes, Alun D.
– sequence: 9
  givenname: Zachary I.
  surname: Whinnett
  fullname: Whinnett, Zachary I.
– sequence: 10
  givenname: Darrel P.
  surname: Francis
  fullname: Francis, Darrel P.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25855674$$D View this record in MEDLINE/PubMed
BookMark eNp1ksuO1TAMhis0iLnAmh3Kkk2ZNGmaZoOERsNFGokNrKM0cU8DbVKS9KDOc_JApOfMQVzEypbs7_8t25fFmfMOiuJ5hV9VWNBrWIKflYacLJTXj4qLilFSEizIWc6xECWriDgvLmP8gjHmRLAnxTlhLWMNry-KH7d7a8BpQGlQCWnv-tHqhALsVDDW7VC094B8jwYFkzerU5PVuRxn72KmPLIuQdiDS8HqZVQBGRjVivyc7GTvVbLebbze9NQBXZ0egnenYhogqHlFU6ZUsFm1D35CxvY9hG22mD3Q4L8jlT38v1Y2oq8wH6aPSbn0tHjcqzHCs4d4VXx-e_vp5n159_Hdh5s3d6Wmgqay0byrSFtjDg3uayBAhMEtM0w0WHDa6S4viRGFO6PbipmWkYZCa4TqMe8YvSpeH3XnpZvA6G0wNco52EmFVXpl5Z8VZwe583tZ83wKirPAyweB4L8tEJOcbNQwjsqBX6KsOKsZIZTz3Prid69fJqdT5gZ2bNDBxxigl9qmw4KztR1lheX2MvL0MvL4Mpm7_os7Sf-P-AnaANE1
CitedBy_id crossref_primary_10_1111_jce_15862
crossref_primary_10_1016_j_hrtlng_2020_07_004
crossref_primary_10_1007_s10840_020_00908_6
crossref_primary_10_1161_CIRCEP_116_004927
crossref_primary_10_1111_jce_14001
crossref_primary_10_1016_j_jacep_2016_02_012
crossref_primary_10_1161_CIRCEP_122_011181
crossref_primary_10_1007_s00399_019_0616_0
crossref_primary_10_1007_s11886_015_0641_5
crossref_primary_10_1093_europace_euac245
crossref_primary_10_1371_journal_pone_0275276
crossref_primary_10_1080_14779072_2018_1427582
crossref_primary_10_1016_j_hrthm_2024_09_012
crossref_primary_10_1016_j_hjc_2017_11_003
crossref_primary_10_1111_pace_14434
Cites_doi 10.1016/j.jcmg.2013.11.001
10.1111/pace.12065
10.1093/europace/eul017
10.1016/0140-6736(92)92492-X
10.1016/j.ijcard.2013.01.216
10.1016/j.ahj.2013.03.021
10.1016/j.hrthm.2006.09.007
10.1093/europace/eun177
10.1111/j.1540-8159.2010.02933.x
10.1136/hrt.2005.080721
10.1093/europace/eus059
10.4236/am.2011.212212
10.1161/CIRCEP.111.964205
10.1016/j.ijcard.2007.08.004
10.1056/NEJMoa050496
10.1007/s10741-010-9203-5
10.1016/j.ijcard.2012.03.128
10.1016/j.jacc.2011.12.030
10.1093/eurjhf/hft139
10.1016/j.jacc.2005.08.032
10.1056/NEJMoa032423
10.1016/j.jacc.2014.06.1175
10.1093/europace/eus222
10.1016/j.ahj.2005.08.019
10.1016/j.jcmg.2012.07.010
10.1136/heartjnl-2012-301877b.3
10.1093/europace/euq167
10.1161/CIRCULATIONAHA.106.634444
ContentType Journal Article
Copyright The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.
The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology 2015
Copyright_xml – notice: The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.
– notice: The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1093/europace/euu374
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-2092
EndPage 1833
ExternalDocumentID PMC4700730
25855674
10_1093_europace_euu374
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: British Heart Foundation
  grantid: FS/11/92/29122
– fundername: British Heart Foundation
  grantid: RG/10/11/28457
– fundername: British Heart Foundation
  grantid: FS/08/027/24763
– fundername: British Heart Foundation
  grantid: FS/13/44/30291
– fundername: British Heart Foundation
  grantid: FS/14/27/30752
– fundername: British Heart Foundation
  grantid: FS/10/038
– fundername: British Heart Foundation
  grantid: FS/10/38/28268
– fundername: British Heart Foundation
  grantid: SP/10/002/28189
GroupedDBID ---
--K
.2P
.I3
.XZ
.ZR
0R~
1B1
1TH
29G
2WC
4.4
48X
53G
5GY
5VS
5WA
6PF
70D
AABZA
AACZT
AAJKP
AAJQQ
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AAUAY
AAUQX
AAVAP
AAWTL
AAYXX
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNHQ
ABNKS
ABPQP
ABPTD
ABQLI
ABVGC
ABWST
ABXVV
ABZBJ
ACGFS
ACPRK
ACUFI
ACUTO
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADOCK
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
AMNDL
APIBT
APWMN
AXUDD
BAWUL
BAYMD
BEYMZ
BHONS
BTRTY
BVRKM
C1A
CAG
CDBKE
CITATION
COF
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IHE
IOX
J21
JXSIZ
KBUDW
KOP
KQ8
KSI
KSN
M-Z
M41
MHKGH
N9A
NGC
NOMLY
NOYVH
NQ-
NTWIH
NU-
O0~
O9-
OAUYM
OAWHX
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
RD5
RIG
ROL
RPM
RPZ
RUSNO
RW1
RXO
SEL
SV3
TCURE
TEORI
TJX
TOX
TR2
UHS
VVN
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c393t-6c7b128407e60f4e2e29d085d5960973bcb56752a0bdc815d85263e8d9af07b53
ISSN 1099-5129
1532-2092
IngestDate Thu Aug 21 14:05:31 EDT 2025
Thu Jul 10 17:28:12 EDT 2025
Mon Jul 21 05:57:17 EDT 2025
Tue Jul 01 04:19:06 EDT 2025
Thu Apr 24 23:04:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Heart failure
Mechanisms
Physiology
Cardiac resynchronization therapy
Language English
License The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c393t-6c7b128407e60f4e2e29d085d5960973bcb56752a0bdc815d85263e8d9af07b53
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC4700730
PMID 25855674
PQID 1754522377
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700730
proquest_miscellaneous_1754522377
pubmed_primary_25855674
crossref_citationtrail_10_1093_europace_euu374
crossref_primary_10_1093_europace_euu374
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-12-01
PublicationDateYYYYMMDD 2015-12-01
PublicationDate_xml – month: 12
  year: 2015
  text: 2015-12-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Europace (London, England)
PublicationTitleAlternate Europace
PublicationYear 2015
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References 2016010504271958000_17.12.1823.15
2016010504271958000_17.12.1823.14
2016010504271958000_17.12.1823.17
2016010504271958000_17.12.1823.16
2016010504271958000_17.12.1823.19
2016010504271958000_17.12.1823.18
2016010504271958000_17.12.1823.11
2016010504271958000_17.12.1823.10
2016010504271958000_17.12.1823.13
2016010504271958000_17.12.1823.12
2016010504271958000_17.12.1823.7
2016010504271958000_17.12.1823.8
2016010504271958000_17.12.1823.5
2016010504271958000_17.12.1823.6
2016010504271958000_17.12.1823.9
2016010504271958000_17.12.1823.26
2016010504271958000_17.12.1823.25
2016010504271958000_17.12.1823.28
2016010504271958000_17.12.1823.27
2016010504271958000_17.12.1823.20
2016010504271958000_17.12.1823.3
2016010504271958000_17.12.1823.22
2016010504271958000_17.12.1823.4
2016010504271958000_17.12.1823.21
2016010504271958000_17.12.1823.1
2016010504271958000_17.12.1823.24
2016010504271958000_17.12.1823.2
2016010504271958000_17.12.1823.23
References_xml – ident: 2016010504271958000_17.12.1823.27
  doi: 10.1016/j.jcmg.2013.11.001
– ident: 2016010504271958000_17.12.1823.11
  doi: 10.1111/pace.12065
– ident: 2016010504271958000_17.12.1823.12
  doi: 10.1093/europace/eul017
– ident: 2016010504271958000_17.12.1823.15
  doi: 10.1016/0140-6736(92)92492-X
– ident: 2016010504271958000_17.12.1823.16
  doi: 10.1016/j.ijcard.2013.01.216
– ident: 2016010504271958000_17.12.1823.6
  doi: 10.1016/j.ahj.2013.03.021
– ident: 2016010504271958000_17.12.1823.4
  doi: 10.1016/j.hrthm.2006.09.007
– ident: 2016010504271958000_17.12.1823.3
  doi: 10.1093/europace/eun177
– ident: 2016010504271958000_17.12.1823.19
  doi: 10.1111/j.1540-8159.2010.02933.x
– ident: 2016010504271958000_17.12.1823.5
  doi: 10.1136/hrt.2005.080721
– ident: 2016010504271958000_17.12.1823.9
  doi: 10.1093/europace/eus059
– ident: 2016010504271958000_17.12.1823.21
  doi: 10.4236/am.2011.212212
– ident: 2016010504271958000_17.12.1823.22
  doi: 10.1161/CIRCEP.111.964205
– ident: 2016010504271958000_17.12.1823.14
  doi: 10.1016/j.ijcard.2007.08.004
– ident: 2016010504271958000_17.12.1823.17
  doi: 10.1056/NEJMoa050496
– ident: 2016010504271958000_17.12.1823.13
  doi: 10.1007/s10741-010-9203-5
– ident: 2016010504271958000_17.12.1823.20
  doi: 10.1016/j.ijcard.2012.03.128
– ident: 2016010504271958000_17.12.1823.23
  doi: 10.1016/j.jacc.2011.12.030
– ident: 2016010504271958000_17.12.1823.24
  doi: 10.1093/eurjhf/hft139
– ident: 2016010504271958000_17.12.1823.7
  doi: 10.1016/j.jacc.2005.08.032
– ident: 2016010504271958000_17.12.1823.18
  doi: 10.1056/NEJMoa032423
– ident: 2016010504271958000_17.12.1823.25
  doi: 10.1016/j.jacc.2014.06.1175
– ident: 2016010504271958000_17.12.1823.1
  doi: 10.1093/europace/eus222
– ident: 2016010504271958000_17.12.1823.10
  doi: 10.1016/j.ahj.2005.08.019
– ident: 2016010504271958000_17.12.1823.26
  doi: 10.1016/j.jcmg.2012.07.010
– ident: 2016010504271958000_17.12.1823.28
  doi: 10.1136/heartjnl-2012-301877b.3
– ident: 2016010504271958000_17.12.1823.2
  doi: 10.1093/europace/euq167
– ident: 2016010504271958000_17.12.1823.8
  doi: 10.1161/CIRCULATIONAHA.106.634444
SSID ssj0007295
Score 2.2113595
Snippet Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1823
SubjectTerms Action Potentials
Atrioventricular Node - physiopathology
Blood Pressure
Cardiac Resynchronization Therapy - adverse effects
Cardiac Resynchronization Therapy - methods
Clinical Research
Electrocardiography
Electrophysiologic Techniques, Cardiac
Female
Heart Block - diagnosis
Heart Block - physiopathology
Heart Block - therapy
Heart Failure - diagnosis
Heart Failure - physiopathology
Heart Failure - therapy
Heart Rate
Hemodynamics
Humans
Male
Time Factors
Treatment Outcome
Title Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant
URI https://www.ncbi.nlm.nih.gov/pubmed/25855674
https://www.proquest.com/docview/1754522377
https://pubmed.ncbi.nlm.nih.gov/PMC4700730
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFICtMiTECxr3MkBG4gEpSpcmcS6PE9o02Doe2kp9i2zHoRFrM62pUPs7-RH8DI5vWXpBGrxEURLHac-X-Bz7XBD6SDmjSSGrBrCUuCFPqJvy2HdznvZzL-U8YjIaeXAVnY_DrxMy6XR-t7yWljXr8fXeuJL_kSocA7nKKNl_kGxzUzgA-yBf2IKEYXsvGduSoKA9gp3PTYSHcyu-S7nLiYJyreYEplTMqlwXn4fTyi1W1cworcujmgekslr4NV05FXxIZiZCUzmeK45U09Wcq3y65qSO31o5M2gl6xkKHbBi665ofy9nWv10ZC2AarercuH8EDfq6aWiurtUQLnYW3ekNYcxrKa0VAtLQ2fgnBRr2viNXKxADrxaNs6b9M5n0pYpGMIr0oxOAypzCa8aV4SqroWJ4DCTI33ScjSx33MfkNHl9npizzE7CMRt2P3WJx0MsGDvWKPzcAnzT6jdZaBLDm3m9b76lp2NLy-z0elk9AA99GPQ8qT6_uWi0RnAxCE6s69-NJuEKg2ObQfH-vab-tOOUbTt29tSlkaH6ImxcvCJRvYp6oj5M_RoYPw4nqNfllwsycWWXNyQiyW5uCpwm1xsycV1hbfJxQon3CZXtjfk4h1ysSEXA7lYkYslubhFLvSBgVy8Ta7pqlxgSS625L5A47PT0edz19QXcXmQBrUb8ZhJ9cyLReQVofCFn-ZgguREpmGMA8YZAXvapx7LedIneUL8KBBJntLCixkJXqKDOaD6GmGein7KKO2DOh6GUZKGJGR5wfwwYWByeF3Us1LLuEm-L2vAXGfaCSTIrJgzLeYu-tQ0uNF5Z_5-6QeLQQZjg1zwo3NRLRcZmAayYEIQx130SmPR3MwnCYFfB63jDWCaC2Te-c0z83Kq8s-HsVzf997co98j9PjutXyLDurbpXgHWnzN3qsX4A8wngpH
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+that+conflict+regarding+size+of+haemodynamic+response+to+interventricular+delay+optimization+of+cardiac+resynchronization+therapy+may+arise+from+differences+in+how+atrioventricular+delay+is+kept+constant&rft.jtitle=Europace+%28London%2C+England%29&rft.au=Sohaib%2C+S+M+Afzal&rft.au=Kyriacou%2C+Andreas&rft.au=Jones%2C+Siana&rft.au=Manisty%2C+Charlotte+H&rft.date=2015-12-01&rft.issn=1532-2092&rft.eissn=1532-2092&rft.volume=17&rft.issue=12&rft.spage=1823&rft_id=info:doi/10.1093%2Feuropace%2Feuu374&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1099-5129&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1099-5129&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1099-5129&client=summon